MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Education level and the onset and severity of symptoms in Huntington’s disease

    SR. Zhang, YF. Cheng, XJ. Gu, KC. Liu, JY. Lin, TM. Yang, Y. Xiao, QR. Jiang, JX. Huang, QQ. Wei, RW. Ou, YB. Hou, LY. Zhang, CY. Li, JM. Burgunder, HF. Shang (Chengdu, China)

    Objective: The current study aimed to investigate the effect of educational level on the clinical characteristics of Chinese patients with Huntington’s disease (HD). Background: Education…
  • 2023 International Congress

    Relationship between bradykinesia and cognitive functions in patients with essential tremor

    G. Paparella, L. Angelini, R. Margiotta, A. Cannavacciuolo, D. Costa, D. Birreci, M. de Riggi, M. Passaretti, D. Alunni Fegatelli, A. Berardelli, M. Bologna (Pozzilli, Italy)

    Objective: To investigate the association between bradykinesia, i.e., movement slowness, as objectively assessed with kinematic analysis, and cognitive functions in ET. Background: Bradykinesia in essential…
  • 2023 International Congress

    Long-term outcomes of deep brain stimulation for VPS16-related dystonia: A multi-center international study

    T. Svorenova, LM. Romito, E. Mulroy, L. Cif, E. Moro, KE. Zeuner, S. Zittel, JN. Petry-Schmelzer, M. Ostrozovicova, V. Han, V. Magocova, K. Knorovsky, A. Kollova, B. Garavaglia, N. Golfrè-Andreasi, C. Reale, A. Mazzoni, A. Kaymak, G. Zorzi, R. Eleopra, V. Levi, T. Foltynie, P. Limousin, H. Akram, L. Zrinzo, F. Magrinelli, D. Murphy, H. Houlden, MA. Kurian, C. Baiata, S. Paschen, K. Lohmann, J. Volkmann, W. Hamel, MT. Barbe, R. Jech, P. Havrankova, J. Winkelmann, M. Zech, M. Skorvanek (Košice, Slovakia)

    Objective: To evaluate long-term effects of DBS in an international cohort of people with VPS16-related dystonia. Background: Variants in VPS16 gene have recently been related…
  • 2023 International Congress

    Motor evaluation of Parkinson disease and Vascular parkinsonism using the TUG encephalog application

    L. Franken, J. Reiner, M. Mermelstein, D. Biederko, R. Djaldettti (Petah Tikva, Israel)

    Objective: We aimed to compare gait and parkinsonian features between PD patients, VP patients and PD patients with Vascular component (PDVC) using a smartphone-based motion…
  • 2023 International Congress

    Parkinson’s Progression Markers Initiative (PPMI) prioritizes enrollment of individuals from diverse and underrepresented populations

    R. Dobkin, M. Kutler, A. O'Grady, C. Kelliher, K. Greenwood, M. Kuhl, S. Fong, S. Mantri (Piscataway, USA)

    Objective: To describe the goals and Year 1 initiatives of PPMI Diversity, Equity, and Inclusion (DEI) taskforce Background: Clinical trials under-enroll people with Parkinson’s disease…
  • 2023 International Congress

    Can the Ohm’s law predict the amplitude of neurostimulation when adapting systems in deep brain stimulation?

    C. Mota, R. Franco, C. Soares, M. Rosas (Porto, Portugal)

    Objective: Review and analysis of clinical and neurostimulation parameters in patients with replacement of constant-voltage non-rechargeable implantable pulse generator (CV-nrIPG) by constant-current rechargeable IPG (CC-rIPG)…
  • 2023 International Congress

    Expanding the clinical phenotype of ataxia associated with PMPCA mutations

    E. Sanesteban Beceiro, A. Fernández Revuelta, R. García-Ramos, E. López Valdés, M. Fenollar Cortés, F. Alonso Frech (Madrid, Spain)

    Objective: To describe two probable cases of autosomal recessive ataxia associated with mutations in the PMPCA gene (ATX-PMPCA) secondary to novel compound heterozygous variants. Background:…
  • 2023 International Congress

    Adult hippocampal neurogenesis-associated memory performance in people with Parkinson’s disease with and without cognitive impairment

    L. Batzu, A. Podlewska, J. Staunton, P. Tall, V. Leta, C. Kim, S. Thuret, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To evaluate the role of adult hippocampal neurogenesis (AHN)-associated memory measures to the cognitive performance of people with Parkinson’s disease (PwP) with or without…
  • 2023 International Congress

    RT-QuIC for detection of pathological α-synuclein in the olfactory mucosa and CSF of Parkinson’s disease patients

    V. Tommasini, M. Bongianni, M. Catalan, D. Perra, P. Polverino, C. Bertolotti, R. Baruca, G. Bellavita, L. Antonutti, G. Zanusso, P. Manganotti (Trieste, Italy)

    Objective: To investigate the proficiency of RT-QuIC in detecting the presence of misfolded α-synuclein (α-syn) on the olfactory mucosa (OM) and CSF of patients with…
  • 2023 International Congress

    Effect of Deep Brain Stimulation on the Motor Profile of Parkinson’s Disease in Egypt; A Developing Country Experience

    S. Abdelaziz, A. Shalash, E. Hamid, Z. Yossry, M. Alkarras, D. Elheraby, Y. Salah, M. Essam, H. Radwan (Cairo, Egypt)

    Objective: To identify the effect of DBS of bilateral STN or bilateral GPi on different motor parameters of PD Background: Deep brain stimulation (DBS) of…
  • « Previous Page
  • 1
  • …
  • 133
  • 134
  • 135
  • 136
  • 137
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson’s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley